|
|
|
|
|
|
|
|
|
|
Glaxosmithkline Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
|
BSE Code |
500660
|
|
ISIN Demat |
INE159A01016
|
|
Book Value (Rs) |
98.85
|
|
|
NSE Code |
GLAXO
|
|
Dividend Yield % |
1.32
|
|
Market Cap(Rs Mn) |
409149.45
|
|
|
TTM PE(x) |
61.17
|
|
TTM EPS(Rs) |
39.49
|
|
Face Value (Rs) |
10
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Glaxosmithkline - MNC |
|
Incorporation Year
|
13-11 1924
|
|
Registered Office
|
Gsk House, Dr. Annie Besant Road,Worli,, Mumbai,
Maharashtra-400030 .
|
|
ISINNO
|
INE159A01016
|
|
Phone
|
022-24959595
|
|
E-mail
|
askus@gsk.com / in.investorquery@gsk.com |
|
URL
|
www.gsk-india.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
R S Karnad
|
|
Managing Director
|
Bhushan Akshikar
|
|
Company Secretary
|
Ajay Nadkarni
|
|
Listing
|
BSE,NSE
|
|
|
|
|